Authors
Latest:
Annual Diabetic Eye Examinations in a Managed Care Medicaid PopulationWe assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.
Latest:
Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in ItalyThis analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.
Latest:
Switching from Multiple Daily Injections to CSII Pump Therapy: Insulin Expenditures in Type 2 DiabetesThe effect of switching from multiple daily insulin injections to an insulin pump on insulin and other diabetic drug expenditures in type 2 diabetes.
Latest:
Antiquated Tests Within the Clinical Pathology LaboratoryPhysicians and laboratorians must work to reduce use of antiquated clinical laboratory tests.
Latest:
An Intervention for VA Patients With Congestive Heart FailureAn intervention of variable intensity for congestive heart failure showed some improvements but no survival effect, suggesting a tradeoff between intervention cost and intensity and survival benefit.
Latest:
5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative ColitisA 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.
Latest:
Development of a Multidisciplinary, Multicampus Subspecialty Practice in Endocrine CancersThe development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.
Latest:
A Health Plan's Investigation of Healthy Days and Chronic ConditionsLinking administrative claims to health-related quality of life measured in Healthy Days provides a new vision into the health of populations.
Latest:
Physician Practice Variation Under Orthopedic Bundled PaymentThis study demonstrates that variation reduction is an important, but not requisite, component of organizational success under orthopedic bundled payment.
Latest:
Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital DischargeThe results of this simulation model suggest that implementing a pharmacist-led medication reconciliation intervention at hospital discharge could be cost-saving compared with usual care.
Latest:
Understanding Suboptimal e-Consult Requests: Lessons From the VAUS Department of Veterans Affairs (VA) clinicians’ perspectives on what constitutes a good e-consult and why suboptimal e-consult requests occur contain broadly applicable lessons for other health systems.
Latest:
Incorporating Health IT Into Primary Care TransformationLongitudinal evaluation of an advanced primary care reform effort found some improvements in health information technology (IT) offerings and use as well as opportunities to improve future collaboration.
Latest:
Trends in the Use of Clinical Decision Support by Health System–Affiliated Ambulatory Clinics in the United States, 2014-2016Use of clinical decision support (CDS) in ambulatory clinics is increasing but remains modest. The CDS function with the greatest use is basic medication screening, which increased from 52% of clinics nationally in 2014 to 61% in 2016.
Latest:
The Budget Impact of Cervical Cancer Screening Using HPV Primary ScreeningThis study assesses the clinical and economic implications from a payer perspective of human papillomavirus genotyping for cervical cancer screening in comparison with existing practices.
Latest:
Impact of Formulary Restrictions on Medication Intensification in Diabetes TreatmentFormulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
Latest:
Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and ConsequencesThis study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.
Latest:
Discharge Before Noon: Is the Sun Half Up or Half Down?Discharge before noon was associated with longer length of stay in patients with medical diagnoses and shorter length of stay in surgical patients.
Latest:
Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.
